MedTrace Logo

A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program

NCT02384109 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 521

Last updated 2019-09-27

No results posted yet for this study

Summary

This proposed project will translate evidence-based strategies for diabetes prevention within the framework of an existing and highly utilized pharmacist-led diabetes care program. Our team includes investigators and practitioners with experience in implementing the DPP (Diabetes Prevention Program) as well as in community-based research. This proposal represents an opportunity to rapidly implement an innovative project addressing a critical area of significant unmet need, as the required key health system and community infrastructure are already in place. The intended outcome is the creation of a practical, effective and sustainable approach to increase evidence-based diabetes prevention strategies that can readily be adopted in other systems.

Conditions

  • Prediabetic State

Interventions

BEHAVIORAL

Shared decision-making with pharmacists

Pharmacist will engage patient using Healthwise (TM) Decision Tool to help match their personal preferences and values with treatment options, specifically lifestyle change with a goal of 7% weight loss or metformin. Patients interested in lifestyle change will be referred to a CDC (Center for Disease Control and Prevention)-approved diabetes prevention program, and pharmacists will coordinate with primary care providers to prescribe metformin for patients interested in this treatment.

OTHER

Standard care from primary care providers

Primary care providers address pre-diabetes as part of usual care, which may involve no action, referrals, or treatment with medications.

Sponsors & Collaborators

Principal Investigators

  • Kenrik Duru, MD, MSHS · University of California, Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02384109 on ClinicalTrials.gov